Introduction
============

The zebrafish *Danio rerio* has become an important vertebrate model organism for a wide range of scientific research questions including development, genetics, and disease \[[@B1]\]. The zebrafish is particularly well suited for this research due to its small size, rapid development, short generation time, optical transparency of embryos and larvae as well as functional conservation of genes \[[@B1]\]. Furthermore, application of drugs is easy since zebrafish readily absorb compounds from their surrounding media \[[@B2]\].

The aim of our study was to determine the composition and to quantify the endogenous level of different cyclic nucleotides (cNMPs) in various developmental stages and organs of *Danio rerio*.

Methods
=======

Wild-type AB zebrafish were mated; for tissue preparation, we harvested embryos at 24 hours post fertilization (hpf) and larvae at 5 days post fertilization (dpf). Organs (eyes, brain, heart, entrails, eggs and testes) from adult female and male wild-type AB zebrafish were dissected according to the guidance of Gupta and Mullins \[[@B3]\]. All samples were then prepared for measurement of cNMP concentrations via a highly sensitive and specific method, namely high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) \[[@B4]\].

Results
=======

We could detect all studied cNMPs (namely cAMP, cCMP, cGMP, cIMP and cUMP) with specific variations as outlined below. (1) cGMP and cAMP could be detected in tissue samples of both developmental stages and within all harvested organs. Remarkably, they are the only cyclic nucleotides detected in brain and entrails. The highest cGMP concentrations were present in eyes; the highest cAMP concentrations in larvae tissue. (2) cIMP was only detected in some organs with the highest concentration in heart. (3) cCMP could not be detected in embryos but in larvae and within several organs. Like cIMP, the highest cCMP concentrations were present in heart. (4) cUMP was detected in both developmental stages as well as in some organs. This cNMP was most abundant within the heart.

Conclusion
==========

The zebrafish *Danio rerio* constitutes a good model organism not only for studies focused on development, genetics and disease but also in the field of cyclic nucleotides, especially related to the role of cNMPs in cardiovascular biology. We observed specific cNMP patterns in development and in different organs, which is in support of the hypothesis of a distinct cNMP signaling code \[[@B5]\].

###### 

cNMP concentrations of zebrafish embryos, larvae and various organs.

  n=2                  cGMP\[pmol/mg protein\]   cIMP\[pmol/mg protein\]   cAMP\[pmol/mg protein\]   cCMP\[pmol/mg protein\]   cUMP\[pmol/mg protein\]
  -------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
  **Embryos 24 hpf**   0.282 ± 0.009             not detected              2.29 ± 0.37               not detected              0.414 ± 0.067
  **Larvae 5 dpf**     1.99 ± 0.32               not detected              23.66 ± 3.97              0.328 ± 0.119             0.890 ± 0.422
  **Eyes**             2.69 ± 0.03               0.111 ± 0.000             2.73 ± 0.34               0.043 ± 0.004             0.087 ± 0.040
  **Brain**            0.149 ± 0.073             not detected              10.02 ± 2.89              not detected              not detected
  **Heart**            0.607 ± 0.124             0.452 ± 0.069             23.12 ± 17.40             0.504 ± 0.143             1.11 ± 0.10
  **Entrails**         0.292 ± 0.031             not detected              16.52 ± 2.30              not detected              not detected
  **Eggs**             0.002 ± 0.003             not detected              0.29 ± 0.02               0.004 ± 0.001             0.008 ± 0.001
  **Testes**           0.802 ± 1.134             0.407 ± 0.037             12.15 ± 3.80              0.116 ± 0.164             0.617 ± 0.052

Future studies
==============

Zebrafish embryos will be treated with the NO-independent sGC activator cinaciguat (BAY 58-2667) and the NO-synergistic sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo\[3,4-b\]pyridine (BAY 41-2272), from one day post fertilization to five days post fertilization. cNMP concentrations and morphological changes will be determined afterwards. Another research area will be the elucidation of the controversial role of cIMP as second messenger \[[@B6],[@B7]\].
